Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

IGF2BP3 and other m6A-related genes are linked to keloid formation and could be potential treatment targets.

Psoriasis is a common, genetically influenced skin disease worsened by stress and lifestyle, but targeted treatments are promising.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

New treatments like JAK inhibitors offer hope for hair regrowth in severe alopecia areata.

Type I interferons play a key role in the development of various skin diseases.

CD8A and FOXD2-AS1 may be key for diagnosing and treating alopecia areata.

Vitamin D3 deficiency can worsen psoriasis by promoting Candida overgrowth.

Vitiligo treatment is improving with new drugs and therapies, focusing on personalized and combined approaches.

Microtrauma techniques like microneedling and PRP can help regrow hair in non-scarring alopecia.

PLA2R1 overexpression harms kidney cells by stopping their growth cycle.

NK cells play a role in skin diseases like eczema and psoriasis.

Removing Ctip2 in skin cells causes skin inflammation similar to atopic dermatitis.

Neuropeptides affect skin inflammation, repair, and hair growth, with potential for therapy.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Biliary fibrosis is crucial in liver diseases and understanding it can help prevent and treat these conditions.

KLB and EIF3C genes are key for early diagnosis of vitiligo and alopecia areata.

Exosomes may help stimulate hair growth and improve hair loss conditions like androgenic alopecia.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

ULBP3 levels are higher in Tinea capitis patients and may help predict the disease's severity.

Experts discussed treatments for skin conditions in children, emphasizing hydration, cautious medication use, and early intervention for infections.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Understanding how our bodies interact with mosquito-borne viruses is crucial because there are few treatments and vaccines.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

Genetic differences affect COVID-19 severity and treatment development.

Wnt signaling is disrupted in asthma, affecting cell growth and inflammation.

Citrullinated proteins from Porphyromonas gingivalis may contribute to rheumatoid arthritis.